School Of Medicine At Mount Sinai Icahn Renalytix PLC (RNLX) insider trading activity

School Of Medicine At Mount Sinai Icahn is of Renalytix plc. Currently has a direct ownership of 19.3 Million shares of RNLX, which is worth approximately $2.9 Million. The most recent transaction as insider was on Apr 24, 2024, when has been sold 9,360,374 shares (Ordinary Shares) at a price of $0.25 per share, resulting in proceeds of $2,340,093. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.3M

0% 3M change

n/a 12M change

Total Value Held $2.9 Million

SCHOOL OF MEDICINE AT MOUNT SINAI ICAHN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 24 2024	BUY Other acquisition or disposition	$2,340,093 $0.25 p/Share	9,360,374 Added 32.64%	19,317,248 Ordinary Shares

Also insider at

SMFR

Sema4 Holdings Corp. Healthcare

> 10% Shareholder

SOM